TVTX logo

Travere Therapeutics (TVTX) Operating profit

annual operating profit:

-$321.39M+$55.35M(+14.69%)
December 31, 2024

Summary

  • As of today (July 1, 2025), TVTX annual operating income is -$321.39 million, with the most recent change of +$55.35 million (+14.69%) on December 31, 2024.
  • During the last 3 years, TVTX annual operating profit has fallen by -$121.96 million (-61.16%).
  • TVTX annual operating profit is now -2530522.05% below its all-time high of -$12.70 thousand, reached on February 28, 2011.

Performance

TVTX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

quarterly operating profit:

-$42.67M+$16.66M(+28.08%)
March 31, 2025

Summary

  • As of today (July 1, 2025), TVTX quarterly operating income is -$42.67 million, with the most recent change of +$16.66 million (+28.08%) on March 31, 2025.
  • Over the past year, TVTX quarterly operating profit has increased by +$96.30 million (+69.29%).
  • TVTX quarterly operating profit is now -1422366.67% below its all-time high of -$3000.00, reached on May 31, 2011.

Performance

TVTX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

TTM operating profit:

-$225.09M+$96.30M(+29.96%)
March 31, 2025

Summary

  • As of today (July 1, 2025), TVTX TTM operating income is -$225.09 million, with the most recent change of +$96.30 million (+29.96%) on March 31, 2025.
  • Over the past year, TVTX TTM operating profit has increased by +$193.27 million (+46.20%).
  • TVTX TTM operating profit is now -7260706.45% below its all-time high of -$3100.00, reached on November 30, 2010.

Performance

TVTX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

TVTX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.7%+69.3%+46.2%
3 y3 years-61.2%+25.2%-3.5%
5 y5 years-222.0%-151.2%-203.4%

TVTX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-61.2%+14.7%at high+69.3%at high+46.2%
5 y5-year-326.4%+14.7%-197.4%+69.3%-225.7%+46.2%
alltimeall time<-9999.0%+14.7%<-9999.0%+69.3%<-9999.0%+46.2%

TVTX Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$42.67M(-28.1%)
-$225.09M(-30.0%)
Dec 2024
-$321.39M(-14.7%)
-$59.33M(+5.9%)
-$321.39M(-6.8%)
Sep 2024
-
-$56.03M(-16.4%)
-$344.89M(-9.6%)
Jun 2024
-
-$67.05M(-51.8%)
-$381.45M(-8.8%)
Mar 2024
-
-$138.98M(+67.8%)
-$418.35M(+11.0%)
Dec 2023
-$376.74M(+17.8%)
-$82.84M(-10.5%)
-$376.74M(-1.0%)
Sep 2023
-
-$92.58M(-10.9%)
-$380.61M(+2.7%)
Jun 2023
-
-$103.95M(+6.8%)
-$370.63M(+13.3%)
Mar 2023
-
-$97.37M(+12.3%)
-$327.22M(+14.1%)
Dec 2022
-$319.81M(+60.4%)
-$86.70M(+5.0%)
-$286.90M(-7.2%)
Sep 2022
-
-$82.60M(+36.4%)
-$309.01M(+26.5%)
Jun 2022
-
-$60.54M(+6.1%)
-$244.25M(+12.3%)
Mar 2022
-
-$57.05M(-47.6%)
-$217.51M(+9.1%)
Dec 2021
-$199.43M(+164.6%)
-$108.81M(+509.7%)
-$199.43M(+72.2%)
Sep 2021
-
-$17.85M(-47.2%)
-$115.83M(+3.1%)
Jun 2021
-
-$33.81M(-13.2%)
-$112.33M(+15.4%)
Mar 2021
-
-$38.96M(+54.5%)
-$97.35M(+29.2%)
Dec 2020
-$75.38M(-24.5%)
-$25.21M(+75.7%)
-$75.38M(+9.1%)
Sep 2020
-
-$14.35M(-23.8%)
-$69.10M(-6.9%)
Jun 2020
-
-$18.82M(+10.8%)
-$74.19M(-16.2%)
Mar 2020
-
-$16.99M(-10.3%)
-$88.54M(-10.7%)
Dec 2019
-$99.81M(+45.3%)
-$18.94M(-2.6%)
-$99.11M(+3.0%)
Sep 2019
-
-$19.44M(-41.4%)
-$96.20M(+0.5%)
Jun 2019
-
-$33.18M(+20.4%)
-$95.74M(+16.8%)
Mar 2019
-
-$27.56M(+72.0%)
-$81.97M(+19.3%)
Dec 2018
-$68.69M(+123.1%)
-$16.02M(-15.6%)
-$68.69M(+17.4%)
Sep 2018
-
-$18.98M(-2.2%)
-$58.52M(+31.3%)
Jun 2018
-
-$19.40M(+35.8%)
-$44.58M(+25.6%)
Mar 2018
-
-$14.29M(+144.3%)
-$35.49M(+10.0%)
Dec 2017
-$30.79M
-$5.85M(+15.9%)
-$32.27M(-11.8%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$5.05M(-51.1%)
-$36.59M(-20.9%)
Jun 2017
-
-$10.31M(-6.8%)
-$46.27M(+3.9%)
Mar 2017
-
-$11.06M(+8.8%)
-$44.54M(+14.1%)
Dec 2016
-$38.94M(+20.7%)
-$10.17M(-30.9%)
-$39.02M(+4.6%)
Sep 2016
-
-$14.72M(+71.4%)
-$37.31M(+18.6%)
Jun 2016
-
-$8.59M(+54.9%)
-$31.47M(+5.9%)
Mar 2016
-
-$5.55M(-34.4%)
-$29.70M(-7.9%)
Dec 2015
-$32.26M(-59.6%)
-$8.45M(-4.8%)
-$32.26M(-24.1%)
Sep 2015
-
-$8.88M(+30.1%)
-$42.51M(-23.4%)
Jun 2015
-
-$6.82M(-15.8%)
-$55.49M(-15.7%)
Mar 2015
-
-$8.10M(-56.7%)
-$65.85M(-17.5%)
Dec 2014
-$79.81M(+222.2%)
-$18.70M(-14.5%)
-$79.81M(+8.8%)
Sep 2014
-
-$21.87M(+27.3%)
-$73.38M(+29.5%)
Jun 2014
-
-$17.18M(-22.1%)
-$56.67M(+27.1%)
Mar 2014
-
-$22.06M(+79.8%)
-$44.58M(+82.7%)
Dec 2013
-$24.77M(-18.1%)
-$12.27M(+138.0%)
-$24.41M(+101.0%)
Sep 2013
-
-$5.15M(+1.1%)
-$12.14M(+73.7%)
Jun 2013
-
-$5.10M(+170.5%)
-$6.99M(+269.0%)
Mar 2013
-
-$1.89M(>+9900.0%)
-$1.89M(>+9900.0%)
Dec 2012
-$30.26M(>+9900.0%)
-
-
Nov 2012
-
-$3200.00(+6.7%)
-$13.00K(+1.6%)
Aug 2012
-
-$3000.00(0.0%)
-$12.80K(0.0%)
May 2012
-
-$3000.00(-21.1%)
-$12.80K(0.0%)
Feb 2012
-
-$3800.00(+26.7%)
-$12.80K(+1.6%)
Feb 2012
-$12.80K(+0.8%)
-
-
Nov 2011
-
-$3000.00(0.0%)
-$12.60K(-0.8%)
Aug 2011
-
-$3000.00(0.0%)
-$12.70K(+30.9%)
May 2011
-
-$3000.00(-16.7%)
-$9700.00(+44.8%)
Feb 2011
-$12.70K
-$3600.00(+16.1%)
-$6700.00(+116.1%)
Nov 2010
-
-$3100.00
-$3100.00

FAQ

  • What is Travere Therapeutics annual operating income?
  • What is the all time high annual operating profit for Travere Therapeutics?
  • What is Travere Therapeutics annual operating profit year-on-year change?
  • What is Travere Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Travere Therapeutics?
  • What is Travere Therapeutics quarterly operating profit year-on-year change?
  • What is Travere Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Travere Therapeutics?
  • What is Travere Therapeutics TTM operating profit year-on-year change?

What is Travere Therapeutics annual operating income?

The current annual operating profit of TVTX is -$321.39M

What is the all time high annual operating profit for Travere Therapeutics?

Travere Therapeutics all-time high annual operating income is -$12.70K

What is Travere Therapeutics annual operating profit year-on-year change?

Over the past year, TVTX annual operating income has changed by +$55.35M (+14.69%)

What is Travere Therapeutics quarterly operating income?

The current quarterly operating profit of TVTX is -$42.67M

What is the all time high quarterly operating profit for Travere Therapeutics?

Travere Therapeutics all-time high quarterly operating income is -$3000.00

What is Travere Therapeutics quarterly operating profit year-on-year change?

Over the past year, TVTX quarterly operating income has changed by +$96.30M (+69.29%)

What is Travere Therapeutics TTM operating income?

The current TTM operating profit of TVTX is -$225.09M

What is the all time high TTM operating profit for Travere Therapeutics?

Travere Therapeutics all-time high TTM operating income is -$3100.00

What is Travere Therapeutics TTM operating profit year-on-year change?

Over the past year, TVTX TTM operating income has changed by +$193.27M (+46.20%)
On this page